<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2016.61009</article-id><article-id pub-id-type="publisher-id">ACM-17157</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20160100000_30776530.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  PCDH10基因DNA甲基化在胃癌中的研究
  Research of PCDH10 DNA Methylation in Gastric Cancer
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>鞠</surname><given-names>亚菲</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>姜</surname><given-names>相君</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>青岛市市立医院消化内科，山东 青岛</addr-line></aff><aff id="aff2"><addr-line>山东省济宁市兖州区中医医院脾胃病科，山东 济宁 </addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>28</day><month>01</month><year>2016</year></pub-date><volume>06</volume><issue>01</issue><fpage>45</fpage><lpage>49</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   
   目的：探讨PCDH10(原钙粘蛋白10)基因DNA发生甲基化后，其表达与胃癌发生的关系。方法：采用甲基化特异性PCR (methy-lation specific PCR)法和实时荧光定量逆转录–多聚合酶链反应(real-time RT-PCR)方法检测100例胃癌组织及正常组织中PCDH10基因启动子区的甲基化情况。结果：胃癌组织中PCDH10基因的甲基化阳性率较正常组织明显升高，差异具有统计学意义。结论：PCDH10的基因DNA甲基化可能与胃癌发生有关。 Objective: To analyze and compare methylation status of PCDH10 gene in gastric cancer and nomal tissues. Methods: Methylation-Specific PCR (MSP) and RT-PCR (real-time RT-PCR) were applied to detect DNA methylation features of the PCDH10 gene in 100 smples. Results: The PCDH10 gene methylation in the gastric cancer tissues was significantly higher than that in normal tissues. Con-clusion: PCDH10 DNA methylation is correlated with gastric cancer.
    
  
 
</p></abstract><kwd-group><kwd>原钙粘蛋白10，甲基化特异性聚合酶链反应，实时荧光定量逆转录–多聚合酶链反应，胃癌, PCDH10</kwd><kwd> MSP</kwd><kwd> RT-PCR</kwd><kwd> Gastric Cancer</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>PCDH10基因DNA甲基化在胃癌中的研究<sup> </sup></title><p>鞠亚菲<sup>1</sup>，姜相君<sup>2*</sup></p><p><sup>1</sup>山东省济宁市兖州区中医医院脾胃病科，山东 济宁</p><p><sup>2</sup>青岛市市立医院消化内科，山东 青岛</p><disp-formula id="hanspub.17157-formula55"><graphic xlink:href="http://html.hanspub.org/file/9-1570198x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>收稿日期：2016年2月25日；录用日期：2016年3月13日；发布日期：2016年3月17日</p><disp-formula id="hanspub.17157-formula56"><graphic xlink:href="http://html.hanspub.org/file/9-1570198x8_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>目的：探讨PCDH10(原钙粘蛋白10)基因DNA发生甲基化后，其表达与胃癌发生的关系。方法：采用甲基化特异性PCR (methy-lation specific PCR)法和实时荧光定量逆转录–多聚合酶链反应(real-time RT-PCR)方法检测100例胃癌组织及正常组织中PCDH10基因启动子区的甲基化情况。结果：胃癌组织中PCDH10基因的甲基化阳性率较正常组织明显升高，差异具有统计学意义。结论：PCDH10的基因DNA甲基化可能与胃癌发生有关。</p><p>关键词 :原钙粘蛋白10，甲基化特异性聚合酶链反应，实时荧光定量逆转录–多聚合酶链反应，胃癌</p><disp-formula id="hanspub.17157-formula57"><graphic xlink:href="http://html.hanspub.org/file/9-1570198x9_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s3"><title>1. 引言</title><p>胃癌是常见的消化道恶性肿瘤，发病机制复杂，其发生发展与特定基因DNA甲基化状态改变密切相关。DNA甲基化是化是目前表观遗传学中的研究热点，特定基因DNA的甲基化与胃癌的发生发展，诊断治疗及预后密切相关。近年来，越来越多的研究结果显示原钙粘蛋白10 (PCDH10)的表达缺失与胃癌，结直肠癌及肝癌密切相关。本文拟通过对比胃癌组织与正常组织中PCDH10启动子区的甲基化情况，初步探讨PCDH10的表达缺失与胃癌的发病关系。</p></sec><sec id="s4"><title>2. 资料与方法</title><sec id="s4_1"><title>2.1. 对象及分组</title><p>收集青岛大学医学院附属青岛市市立医院普外科2014年1月~2015年1月手术切除的胃癌肿瘤标本100例，标本均经病理科复核并确诊为原发性胃癌，其中男50例，女50例，平均年龄53.76岁 &#177; 11.89岁。</p></sec><sec id="s4_2"><title>2.2. 标本搜集及储存</title><p>胃癌组织取自癌灶中央非坏死区域，正常组织取自与之配对的距离癌组织5 cm以上区域，取后立即置于RNA保存液中，−80℃冰箱保存，用于提取DNA和RNA，入选患者术中均行淋巴结清扫，术前未行放化疗，拥有完整的临床资料。</p></sec><sec id="s4_3"><title>2.3. 检测指标及方法</title><p>组织DNA提取严格按照离心柱试剂盒(北京天根)操作说明书进行，保证提取的DNA无蛋白质及RNA污染。对DNA修饰后进行甲基化特异性PCR (methy-lation specific PCR)，提取RNA采用日本TakaRa公司的RNA提取试剂盒，提取后的RNA逆转录为cDNA保存于−20℃冰箱中，以进行RT-PCR反应。反应引物为PCDH10-F (bp120－GGCAAGTAACGGTGGAGATG.PCDH10-R(bp228C)-TCTCCGGATGGA TGTTCTTC (Invitrogen英潍捷基上海贸易有限公司)。</p></sec><sec id="s4_4"><title>2.4. 统计学处理</title><p>应用SPSS17.0软件包进行统计学处理，计数资料比较采用χ2检验，P为双侧性检验，P &lt; 0.05认为差异有统计学意义。</p></sec></sec><sec id="s5"><title>3. 结果</title><p>胃癌组织与正常组织中PCDH10启动子区的甲基化情况：胃癌组织中启动子区甲基化率为46.00% (46/100)，明显高于正常组织12% (12/100)，差异有统计学意义(χ2 = 21.04, P &lt; 0.05)。PCDH10扩增曲线熔解曲线见图1，熔解曲线见图2。在胃癌组织中，PCDH10基因启动子区域的DNA甲基化导致了其基因表达缺失，PCDH10基因的甲基化状态与胃癌的发生有密切关系。</p><p>图1. PCDH10扩增曲线</p><p>图2. PCDH10熔解曲线</p></sec><sec id="s6"><title>4. 讨论</title><p>DNＡ甲基化是对DNA的一种化学修饰，主要发生于胞嘧啶 [<xref ref-type="bibr" rid="hanspub.17157-ref1">1</xref>] [<xref ref-type="bibr" rid="hanspub.17157-ref2">2</xref>] ，通过甲基转移酶(DNA methyltransferance, DNMT)来实现 [<xref ref-type="bibr" rid="hanspub.17157-ref3">3</xref>] [<xref ref-type="bibr" rid="hanspub.17157-ref4">4</xref>] 。首先，DNMT与DNA结合，将目标核苷酸反转暴露于DNA双螺旋外，之后半胱氨酸的亲和基团与胞嘧啶第六位碳C6共价结合，从S-腺苷甲硫氨酸SAM处转甲基至胞嘧啶C5 [<xref ref-type="bibr" rid="hanspub.17157-ref5">5</xref>] 上，从而形成甲基化状态。目前已有许多研究报道这两种之间的关系。Lou J [<xref ref-type="bibr" rid="hanspub.17157-ref6">6</xref>] 和Fang JY [<xref ref-type="bibr" rid="hanspub.17157-ref7">7</xref>] 等发现在胃癌组织中c-myc和c-Ha-ras基因甲基化水平降低，c-Ha-ras基因低甲基化是胃腺细胞早期癌变的一个重要遗传学事件。以往研究也证实了参与调节细胞周期的p14，p15，p16，CHF，RIZI基因，介导细胞信号转导的APC，PTEN，RASSF1，RUNX3，PDK1基因；参与DNA修复的hMLH1，MGMT，pS2基因及抑制肿瘤扩散生长和转移的E-cadherin，TIMP-3基因存在高甲基化。</p><p>PCDH10 (原钙粘蛋白10)是钙粘蛋白超家族成员，其4q28.3染色体区域在肝癌，结直肠癌，前列腺癌，胰腺癌和乳腺癌中存在缺失。目前研究的热点集中于中枢神经系统方面，在消化道肿瘤方面的研究较少。Zhong X等 [<xref ref-type="bibr" rid="hanspub.17157-ref8">8</xref>] 研究发现在8个结直肠癌细胞系中PCDH10基因启动子区DNA均表达沉默。Fang S等 [<xref ref-type="bibr" rid="hanspub.17157-ref9">9</xref>] 研究了PCDH10基因DNA发生甲基化后，在肝癌中的表达下降，并发现该基因可作为肝癌的筛查基因之一。Li Z等 [<xref ref-type="bibr" rid="hanspub.17157-ref10">10</xref>] 发现在人胃癌组织中，PCDH10表达量明显下降，且灵敏度较高，可作为筛查早期胃癌的靶点之一。Yu B等人 [<xref ref-type="bibr" rid="hanspub.17157-ref11">11</xref>] 运用高分辨率熔解曲线技术对100例胃癌，100例结直肠癌及70例胰腺癌组织中的PCDH10基因DNA甲基化水平进行检测，发现其甲基化水平与肿瘤的发生密切相关。Yu J等人 [<xref ref-type="bibr" rid="hanspub.17157-ref12">12</xref>] 研究发现PCDH10作为一个肿瘤抑制基因，与胃癌的不良预后有极为密切的关系。</p><p>本实验表明，在胃癌组织中，PCDH10基因启动子区域的DNA甲基化导致了其基因表达缺失，PCDH10基因的甲基化状态与胃癌的发生有密切关系，更深层次的研究需在大样本的条件下进一步深入。</p></sec><sec id="s7"><title>基金项目</title><p>青岛市科技局基金资助项目，No. 2012-1-3 -1-(10)。</p></sec><sec id="s8"><title>文章引用</title><p>鞠亚菲,姜相君. PCDH10基因DNA甲基化在胃癌中的研究Research of PCDH10 DNA Methylation in Gastric Cancer[J]. 临床医学进展, 2016, 06(01): 45-49. http://dx.doi.org/10.12677/ACM.2016.61009</p></sec><sec id="s9"><title>参考文献 (References)</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.17157-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Klose, R.J. and Bird, A.P. (2006) Genomic DNA Methylation: The Mark and Its Mediators. Trends in Biochemical Sciences, 31, 89-97. &lt;br&gt;http://dx.doi.org/10.1016/j.tibs.2005.12.008</mixed-citation></ref><ref id="hanspub.17157-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Gupta, R., Nagarajan, A. and Wajapeyee, N. (2010) Advances in Genome-Wide DNA Methylation Analysis. BioTechniques, 49, iii-xi. &lt;br&gt;http://dx.doi.org/10.2144/000113493</mixed-citation></ref><ref id="hanspub.17157-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Goll, M.G. and Bestor, T.H. (2005) Eukaryotic Cytosine Methyltrans-ferases. Annual Review of Biochemistry, 74, 481- 514. &lt;br&gt;http://dx.doi.org/10.1146/annurev.biochem.74.010904.153721</mixed-citation></ref><ref id="hanspub.17157-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Lee, T.F., Zhai, J. and Meyers, B.C. (2010) Conservation and Divergence in Eukaryotic DNA Methylation. Proceedings of the National Academy of Sciences of USA, 107, 9027-9028. &lt;br&gt;http://dx.doi.org/10.1073/pnas.1005440107</mixed-citation></ref><ref id="hanspub.17157-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Cheng, X. and Blumenthal, R.M. (2008) Mammalian DNA Methyltransferases: A Structural Perspective. Structure, 16, 341-350. &lt;br&gt;http://dx.doi.org/10.1016/j.str.2008.01.004</mixed-citation></ref><ref id="hanspub.17157-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Luo, J., Li, Y.N., Wang, F., et al. (2010) S-Adenosylmethionine Inhibits the Growth of Cancer Cells by Reversing the Hypomethylation Status of c-myc and H-ras in Human Gastric Cancer and Colon Cancer. International Journal of Biological Sciences, 6, 784-795. &lt;br&gt;http://dx.doi.org/10.7150/ijbs.6.784</mixed-citation></ref><ref id="hanspub.17157-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Fang, J.Y., Cheng, Z.H., Chen, Y.X., et al. (2001) Expression of Dnmtl 1, Demethylase, MeCP2 and Methylation of Tumor-Related Genes in Human Gastric Cancer. World Journal of Gas-troenterology, 10, 3394-3398.  
&lt;br&gt;http://dx.doi.org/10.3748/wjg.v10.i23.3394</mixed-citation></ref><ref id="hanspub.17157-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Zhong, X., Zhu, Y., Mao, J., et al. (2013) Frequent Epigenetic Silencing of PCDH10 by Methylation in Human Colorectal Cancer. Journal of Cancer Research and Clinical Oncology, 139, 485-90.  
&lt;br&gt;http://dx.doi.org/10.1007/s00432-012-1353-5</mixed-citation></ref><ref id="hanspub.17157-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Fang, S., Huang, S.F., Cao, J., et al. (2013) Silencing of PCDH10 in Hepatocellular Carcinoma via de Novo DNA Methylation Independent of HBV Infection or HBX Expres-sion. Clinical and Experimental Medicine, 13, 127-134.  
&lt;br&gt;http://dx.doi.org/10.1007/s10238-012-0182-9</mixed-citation></ref><ref id="hanspub.17157-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Li, Z., Chim, J.C., Yang, M., et al. (2012) Role of PCDH10 and Its Hypermethylation in Human Gastric Cancer. Biochimica et Biophysica Acta, 1823, 298-305. &lt;br&gt;http://dx.doi.org/10.1016/j.bbamcr.2011.11.011</mixed-citation></ref><ref id="hanspub.17157-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Yu, B., Yang, H. and Zhang, C. (2010) High-Resolution Melting Analysis of PCDH10 Methylation Levels in Gastric, Colorectal and Pancreatic Cancers. Neoplasma, 57, 247-252. &lt;br&gt;http://dx.doi.org/10.4149/neo_2010_03_247</mixed-citation></ref><ref id="hanspub.17157-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Yu, J., Cheng, Y.Y. and Tao, Q. (2009) Methylation of Protocadherin 10, a Novel Tumor Suppressor, Is Associated with Poor Prognosis in Patients with Gastric Cancer. Gastroenterology, 136, 640-651.e1.  
&lt;br&gt;http://dx.doi.org/10.1053/j.gastro.2008.10.050</mixed-citation></ref></ref-list></back></article>